An interesting prognostic model in MAFLD patients with SARS-CoV-2 infection has been developed by Macías-Rodríguez et al.; this model, called the liver fibrosis and nutrition (LFN)-COVID-19 index, is based on lactate dehydrogenase and transaminases (AST/ALT), and shows a good performance to predict poor outcomes (acute kidney injury, intubation, death) when the value is >1.67. Here, GPT is linked to Hepatic fibrosis.